Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abecma Approval In Earlier Myeloma Carries Caution On Early Death Data

Apr 06 2024

• By Bridget Silverman

BMS (Bristol) building — • Source: Shutterstock

Related Content

‘The Run Is Worth The Slide:’ FDA Advisors Urge Expansion Of J&J’s CAR-T Carvykti Despite Initial Upfront Treatment Risks

Mar 16 2024

BMS And J&J CAR-Ts Flagged For Early Deaths Ahead of Back-To-Back FDA Advisory Panels

Mar 14 2024

Related Companies

Bristol Myers Squibb Company

2seventy Bio, Inc.

Johnson & Johnson

Additional Topics

United States Drug Safety Approvals Drug Approval Standards Drug Review Regulation US FDA Performance Tracker Cancer Oncology BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window